GARY LYMAN was named co-director of The Hutchinson Institute for Cancer Outcomes Research, based at the Fred Hutchinson Cancer Research Center. He will co-lead with Scott Ramsey, a member of the Cancer Prevention Program in the Public Health Sciences Division at Fred Hutch.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
